01 Mar Ischemic Postconditioning During Primary PCI for Patients With STEMI Heart Attack
MedicalResearch.com Interview with:
Thomas Engstrøm MD, PhD
The Heart Center | Rigshospitalet | University of Copenhagen | Denmark
Professor in cardiology | University of Lund | Sweden
Adjunct professor in cardiology | University of Aalborg | Denmark
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Timely reperfusion by primary angioplasty (primary PCI) in patients with ST-elevation myocardial infarction is mandatory. However reperfusion it self can harm the myocardium – so called reperfusion injury. During a number of years ischemic postconditioning (iPOST) by repetitive interruptions of blood flow after reperfusion has been a promising technique to address reperfusion damage.
The trial investigated the effect of iPOST in 1200 patients treated with primary PCI and in addition either iPOST or conventional angioplasty.
MedicalResearch.com: What should readers take away from your report?
Response: The trial was neutral and thus a large number of positive clinical studies on surrogate endpoints could not be translated into a clinical outcome study.
MedicalResearch.com: What recommendations do you have for future research as a result of this study?
Response: Since reperfusion injury is real and it may in some patients account for up to 50% of the final myocardial injury research within the area should be continued. Remote ischemic conditioning and pharmacological compounds are candidates as future treatment modalities.
MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.
Citation:
Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.
More Medical Research Interviews on MedicalResearch.com
[wysija_form id=”5″]
Last Updated on March 1, 2017 by Marie Benz MD FAAD